amneal.com (AMRX) Company Sales Revenue

amneal.com - graphic logo of issuer AMRX

The reliability of Amneal Pharmaceuticals (AMRX) guarantees stable demand for affordable medications regardless of economic conditions. The company's current sales levels confirm this resilience, where the value of 3.20 characterizes this level. The business's defensive status minimizes the impact of crises, while diversification between biosimilars and neurology effectively offsets pricing risks, creating a balanced revenue stream.

Amneal Pharmaceuticals (AMRX): Company Revenue from 07/04/2022 to 11/18/2026

Comprehensive metric breakdowns and analytics for amneal.com (AMRX)

- market price and analyst price targets:
Summary company analysis:AMRX, amneal.com
Product sample of Amneal Pharmaceuticals

Amneal Pharmaceuticals' exit from generic stagnation and the launch of complex biosimilars directly determine the upward trajectory of the company's execution history. This indicator captures the average daily cash inflow, transforming total revenue into a precise capital inflow rate, which allows investors to assess the business's real momentum and the fundamental stability of the asset's market capitalization.

Analysis of competing companies

HLN: Company Sales Revenue|Company Revenue Kenvue (KVUE)|VRNA (Verona Pharma Corp) - Company Sales Revenue|Company Revenue Jyong Biotech MENS|Ligand Pharma - Company Revenue|Perrigo Company PLC - Revenue and Sales Volume|ALVO: Company Revenue|liquidia.com (LQDA) - Company Revenue|GLPG (Galapagos) - Company Revenue|Company Sales ANIP|Company Sales Volume MNKD (Afrezza)|Revenue and Sales Volume AMPH|PCRX (Pacira BioSciences) - Company Sales Revenue|Revenue and Sales Volume SPRY (ARS Pharmaceuticals, Inc.)|Theravance Biopharma, Inc. - Company Revenue|Aquestive Corp - Revenue and Sales Volume|scpharmaceuticals.com (SCPH) - Company Sales|TECX: Revenue and Sales Volume|Tonix Pharmaceuticals - Company Sales Revenue|Company Sales SXTC|EPRX: Company Sales Revenue|Company Sales BHST (BioHarvest Sciences Inc.)|Company Gross Revenue Invizyne|Company Revenue Oramed Pharmaceuticals ORMP|Company Sales Revenue ENTX|HYFT - Company Revenue|Company Sales Revenue ABVC (ABVC BioPharma Inc.)|CPIX: Revenue and Sales Volume|Quantum BioPharma Limited - Company Sales Revenue|FGEN (FibroGen Corp) - Revenue and Sales Volume|Revenue and Sales Volume Telomir Pharmaceuticals|Revenue and Sales Volume RANI|SNYR (Synergy CHC Corp.) - Company Sales Revenue|Revenue and Sales Volume RLYB (Rallybio Corp)|LEXX: Company Sales Volume|PULM - Company Revenue|PTHL: Company Revenue|APM (aptorumgroup.com) - Company Sales|Lyra Therapeutics - Company Sales Revenue|Company Revenue Impact BioMedical Inc|TNF Pharmaceuticals, Inc. (TNFA) - Company Gross Revenue|Revenue and Sales Volume YCBD|PRFX: Company Annual Revenue|Company Revenue altamiratherapeutics.com CYTO|Revenue and Sales Volume Lipella Pharmaceuticals Inc LIPO|OPTN - Company Revenue|Company Gross Revenue Pieris Pharma PIRS|Procaps Group SA (PROC) - Company Revenue|Company Annual Revenue PTPI (Petros Pharmaceuticals, Inc.)|QLI (Qilian International Holding) - Revenue and Sales Volume|SLRN: Company Sales Revenue|Revenue and Sales Volume TFFP